Our presence throughout the world
As in Italy, Biomedica Foscama Group is strongly committed to become in the future, leading of the pharmaceuticals markets in Europe and all over the world and already works towards achieving this goal. Our strategy is based on scientific knowledge of our medicines and food supplements through local distributors, clinical meetings, conferences and symposiums. The export business began in 1987 with a small turnover, today covers 40% of the total turnover. good sales performance is primarily due to two leading drugs : TAD and Esafosfina, to which in 2011 was added a third drug: Legend, with the collaboration of partner ns.
- Repubblica popolare di Cina
- Emirati Arabi
- Arabia Saudita
The active substance of legend is S-Adenosyl-methionine and it has been developed in collaboration with a major international company which markets the product in several countries. Biomedica Foscama Group as well as producing LEGEND, has performed the preparation of the registration dossiers in order to allow the expansion of the product worldwide . Biomedica Foscama Group distributes and sells in foreign markets Food Supplements of which is the Marketing Authorisation Holder. Biomedica Foscama Group is currently investing in manufacturing processes and services, especially with regard to Esafosfina and TAD, in order to satisfy increasing demand from new markets. All stages in the manufacturing process comply strictly with GMPs and technical/ scientific information are continuously updated to ensure safe and effective end products. Our products are currently sold and appreciated in a large number of Countries. Where we are: People’s Republic of China, Thailand, Kuwait, the Philippines, Lebanon, Azerbaijan, Kazakhstan, Kyrgyzstan, Georgia, Russia and Vietnam. Where we are going: Czech Republic, Poland, Republic of Macedonia, Serbia, E.A.U., Saudi Arabia, Egypt, Korea, Singapore, Malaysia, Pakistan and Indonesia .. and more.